Demographic , Clinicopathological Characteristics and Survival of Breast Cancer

Breast Carcinoma Clinical Trial

Official title:

Demographic, Clinicopathological Characteristics and Survival of Breast Cancer Patients in Assiut University Hospital (2015-2019).

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04316247
• Other study ID #: Neveen
• Status: Not yet recruiting
• Start date: April 1, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: March 2020
• Source: Assiut University
• Contact: Neveen N Kamel, doctor
• Phone: +201287668559
• Email: neveenemanuel[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators will retrospectively study the demographic , clinicopathological characteristics and survival of breast cancer patients admitted to Assiut University hospital from the year 2015 to 2019

Description:

Breast cancer is one of the most common malignancies in females, which is the second leading cause of cancer death throughout the world after lung cancer . The incidence of breast cancer has been increasing over the past decades , especially in young women (≤ 35 years old). There is approximately 182,000 women with breast neoplasm annually in the United States, accounting for about 26% of all incident cancers among women.

In Asia, the morbidity rate is as high as 9.5%-12% . Even worse in China, the average onset age of breast cancer might be 8-10 years younger than that in Western countries which account for upto 4% in total breast cancer patients .

In Egypt, breast cancer is the commonest type of female malignancy represented about 38.8% among common cancer sites in females.Although The unclear etiology of the majority of breast cancer, but there are numerous risk factors for the disease. Screening and early detection when combined with adequate, efficient treatment is considered the hope for a reduction of mortality in breast cancer as postulated by World Health organization (WHO).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• All histologically confirmed and documented patients with invasive ductal or lobular carcinoma of the breast attending at Assiut University hospital from year 2015 to 2019.

Exclusion Criteria:

• • Patients who previously received treatment outside Assiut University hospital.

• A serious un controlled concomitant disease that would contraindicate with use of systemic treatment. .

Related Conditions & MeSH terms

• Breast Carcinoma
• Breast Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

References & Publications (1)

Chen S, Chen H, Yi Y, Jiang X, Lei H, Luo X, Chen Y, Liu S, Yuan D, Jia X, Li J. Comparative study of breast cancer with or without concomitant Paget disease: An analysis of the SEER database. Cancer Med. 2019 Jul;8(8):4043-4054. doi: 10.1002/cam4.2242. E — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The survival rate of breast cancer in assiut university hospital	The number of patients survived after surgery or chemotherapy	One year